|
TCMBANKGE000181 |
PIM1 |
PIM |
Pim-1 proto-oncogene, serine/threonine kinase |
|
TCMBANKGE000201 |
ESR1 |
ER; ESR; ESRA; ESTRR; Era; NR3A1 |
estrogen receptor 1 |
|
TCMBANKGE000205 |
NOS2 |
HEP-NOS; INOS; NOS; NOS2A |
nitric oxide synthase 2 |
|
TCMBANKGE000286 |
GSK3B |
- |
glycogen synthase kinase 3 beta |
|
TCMBANKGE000309 |
SCN5A |
CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 |
sodium voltage-gated channel alpha subunit 5 |
|
TCMBANKGE000360 |
CCNA2 |
CCN1; CCNA |
cyclin A2 |
|
TCMBANKGE000633 |
ADRB2 |
ADRB2R; ADRBR; B2AR; BAR; BETA2AR |
adrenoceptor beta 2 |
|
TCMBANKGE000701 |
ESR2 |
ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 |
estrogen receptor 2 |
|
TCMBANKGE000813 |
DPP4 |
ADABP; ADCP2; CD26; DPPIV; TP103 |
dipeptidyl peptidase 4 |
|
TCMBANKGE000903 |
PTGS1 |
COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS |
prostaglandin-endoperoxide synthase 1 |
|
TCMBANKGE000938 |
CDK2 |
CDKN2; p33(CDK2) |
cyclin dependent kinase 2 |
|
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
|
TCMBANKGE001202 |
MAPK14 |
CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA |
mitogen-activated protein kinase 14 |
|
TCMBANKGE004266 |
AR |
AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM |
androgen receptor |
|
TCMBANKGE005535 |
CHRM1 |
HM1; M1; M1R |
cholinergic receptor muscarinic 1 |
|
TCMBANKGE006943 |
CHRM3 |
EGBRS; HM3; PBS |
cholinergic receptor muscarinic 3 |
|
TCMBANKGE008702 |
OPRM1 |
LMOR; M-OR-1; MOP; MOR; MOR1; OPRM |
opioid receptor mu 1 |
|
TCMBANKGE008921 |
RXRA |
NR2B1 |
retinoid X receptor alpha |
|
TCMBANKGE014050 |
GABRA1 |
ECA4; EIEE19; EJM; EJM5 |
gamma-aminobutyric acid type A receptor subunit alpha1 |
滇ICP备16009434号-1 |
Dai SX Lab